Erythropoietin human recombinant (EPOrh) ( DrugBank: Erythropoietin )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 6 | パーキンソン病 | 1 |
6. パーキンソン病
臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01010802 (ClinicalTrials.gov) | August 2008 | 8/11/2009 | Safety Study of Erythropoietin (EPO) in Parkinson's Disease | Phase 1 Study of Recombinant Human Erythropoietin (rhEPO) in Parkinson's Disease (PD) | Parkinson Disease | Drug: Erythropoietin human recombinant (EPOrh) | International Center for Neurological Restoration, Cuba | Centro de Immunologia Molecular, Cuba | Completed | 45 Years | 75 Years | All | 10 | Phase 1 | Cuba |